{"id":12067,"date":"2025-07-22T08:24:08","date_gmt":"2025-07-22T12:24:08","guid":{"rendered":"https:\/\/www.rigicon.com\/glossary-term\/active-monitoring\/"},"modified":"2025-07-22T08:24:08","modified_gmt":"2025-07-22T12:24:08","slug":"monitorizacion-activa","status":"publish","type":"glossary-term","link":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","title":{"rendered":"Monitorizaci\u00f3n Activa"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","glossary-category":[126],"glossary-product":[],"class_list":["post-12067","glossary-term","type-glossary-term","status-publish","hentry","glossary-category-urological-conditions"],"acf":{"gt-definition":"<p>El monitoreo activo, tambi\u00e9n conocido como vigilancia activa, es una estrategia de observar de cerca una afecci\u00f3n sin tratamiento inmediato, interviniendo solo si se produce progresi\u00f3n.<sup>1<\/sup> Este enfoque implica un monitoreo regular a trav\u00e9s de pruebas y ex\u00e1menes programados para rastrear cualquier cambio en la afecci\u00f3n.<sup>2<\/sup> Se utiliza principalmente para afecciones que crecen lentamente o presentan un riesgo inmediato m\u00ednimo, particularmente en los casos en los que los posibles efectos secundarios del tratamiento pueden ser mayores. los beneficios de la intervenci\u00f3n inmediata.<sup>3<\/sup> El monitoreo activo permite a los proveedores de atenci\u00f3n m\u00e9dica retrasar o evitar tratamientos innecesarios mientras mantienen la capacidad de intervenir r\u00e1pidamente si la afecci\u00f3n empeora.<sup>4<\/sup> Este enfoque se implementa m\u00e1s com\u00fanmente en el tratamiento del c\u00e1ncer de pr\u00f3stata de bajo riesgo, pero tambi\u00e9n se puede aplicar a otras afecciones.<sup>5<\/sup><\/p>","gt-synonyms":"Vigilancia activa, espera vigilante, manejo expectante, observaci\u00f3n, protocolo de vigilancia, protocolo de seguimiento, tratamiento diferido","gt-citation":"[1] Cooperberg MR, Meeks W, Fang R, Gaylis FD, Catalona WJ, Makarov DV. Time Trends and Variation in the Use of Active Surveillance for Management of Low-risk Prostate Cancer in the US. JAMA Netw Open. 2023;6(3):e231439. DOI: 10.1001\/jamanetworkopen.2023.1439\n\n[2] National Cancer Institute. Definition of active surveillance. Cancer.gov. https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-terms\/def\/active-surveillance. Accessed June 2, 2025.\n\n[3] Mayo Clinic. Active surveillance for prostate cancer. https:\/\/www.mayoclinic.org\/tests-procedures\/active-surveillance-for-prostate-cancer\/about\/pac-20384946. Actualizado November 15, 2023. Accessed June 2, 2025.\n\n[4] American Cancer Society. Observation or Active Surveillance for Prostate Cancer. https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/treating\/watchful-waiting.html. Actualizado November 22, 2023. Accessed June 2, 2025.\n\n[5] Moore CM, Giganti F, Albertsen P, et al. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer: A Consensus Statement from the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Initiative. Eur Urol Oncol. 2023;6(2):155-165. DOI: 10.1016\/j.euo.2023.01.001","gt-clinical-context":"<p>La monitorizaci\u00f3n activa se utiliza principalmente en entornos cl\u00ednicos donde la intervenci\u00f3n inmediata puede no ser necesaria o beneficiosa.<sup>1<\/sup> La aplicaci\u00f3n m\u00e1s com\u00fan es en el tratamiento del c\u00e1ncer de pr\u00f3stata de bajo riesgo, donde se ha convertido en el enfoque preferido seg\u00fan las principales directrices cl\u00ednicas.<sup>2<\/sup> Esta estrategia es particularmente apropiada para pacientes con tumores peque\u00f1os y de crecimiento lento que est\u00e1n confinados a un \u00e1rea espec\u00edfica y no causan s\u00edntomas.<sup>3<\/sup><\/p>\n\n<p>Los criterios de selecci\u00f3n de pacientes para la monitorizaci\u00f3n activa suelen incluir:<\/p>\n<ul>\n    <li>Clasificaci\u00f3n de enfermedades de bajo riesgo (p. ej., puntuaci\u00f3n de Gleason baja en el c\u00e1ncer de pr\u00f3stata)<sup>4<\/sup><\/li>\n    <li>Extensi\u00f3n limitada de la enfermedad (p. ej., confinada a un \u00e1rea)<sup>3<\/sup><\/li>\n    <li>Ausencia de s\u00edntomas relacionados con la condici\u00f3n<sup>3<\/sup><\/li>\n    <li>Consideraci\u00f3n de la edad del paciente y comorbilidades que podr\u00edan limitar la esperanza de vida<sup>4<\/sup><\/li>\n<\/ul>\n\n<p>El protocolo de seguimiento generalmente implica:<\/p>\n<ul>\n    <li>Visitas m\u00e9dicas peri\u00f3dicas (normalmente cada 3 a 6 meses)<sup>4<\/sup><\/li>\n    <li>An\u00e1lisis de sangre peri\u00f3dicos (p. ej., prueba de PSA en el c\u00e1ncer de pr\u00f3stata)<sup>4<\/sup><\/li>\n    <li>Estudios de im\u00e1genes a intervalos definidos (p. ej., resonancia magn\u00e9tica)<sup>5<\/sup><\/li>\n    <li>Repetir biopsias cuando lo indiquen cambios en otros par\u00e1metros<sup>5<\/sup><\/li>\n<\/ul>\n\n<p>Los resultados esperados con el monitoreo activo incluyen:<\/p>\n<ul>\n    <li>Evitaci\u00f3n de efectos secundarios innecesarios del tratamiento para muchos pacientes<sup>4<\/sup><\/li>\n    <li>Preservaci\u00f3n de la calidad de vida durante el per\u00edodo de seguimiento<sup>4<\/sup><\/li>\n    <li>Sin impacto significativo en la supervivencia espec\u00edfica del c\u00e1ncer para pacientes adecuadamente seleccionados<sup>5<\/sup><\/li>\n    <li>Posible retraso en la intervenci\u00f3n si se detecta progresi\u00f3n<sup>5<\/sup><\/li>\n<\/ul>\n\n<p>La decisi\u00f3n de pasar de la monitorizaci\u00f3n activa al tratamiento activo generalmente se basa en evidencia de progresi\u00f3n de la enfermedad, como niveles crecientes de biomarcadores, cambios en los hallazgos de las im\u00e1genes o empeoramiento de los s\u00edntomas.<sup>5<\/sup><\/p>","gt-related-evidence":null,"gt-featured":true,"gt-ai-referenced":false,"gt-view-count":64},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v27.9) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Monitorizaci\u00f3n Activa<\/title>\n<meta name=\"description\" content=\"La monitorizaci\u00f3n activa es una estrategia m\u00e9dica que observa de cerca las condiciones sin tratamiento inmediato...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monitorizaci\u00f3n Activa - Prosthetic Urology Glossary\" \/>\n<meta property=\"og:description\" content=\"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/\",\"name\":\"Monitorizaci\u00f3n Activa\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#website\"},\"datePublished\":\"2025-07-22T12:24:08+00:00\",\"description\":\"La monitorizaci\u00f3n activa es una estrategia m\u00e9dica que observa de cerca las condiciones sin tratamiento inmediato...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/glossary-term\\\/monitorizacion-activa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glossary Terms\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/urology-glossary\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Monitorizaci\u00f3n Activa\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/es\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Monitorizaci\u00f3n Activa","description":"La monitorizaci\u00f3n activa es una estrategia m\u00e9dica que observa de cerca las condiciones sin tratamiento inmediato...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","og_locale":"es_ES","og_type":"article","og_title":"Monitorizaci\u00f3n Activa - Prosthetic Urology Glossary","og_description":"Explore Rigicon\u2019s evidence-based glossary covering penile implants, AUS, ED treatments, and surgical terms in prosthetic urology.","og_url":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/05\/header-d.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","url":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/","name":"Monitorizaci\u00f3n Activa","isPartOf":{"@id":"https:\/\/www.rigicon.com\/es\/#website"},"datePublished":"2025-07-22T12:24:08+00:00","description":"La monitorizaci\u00f3n activa es una estrategia m\u00e9dica que observa de cerca las condiciones sin tratamiento inmediato...","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/es\/glossary-term\/monitorizacion-activa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.rigicon.com\/es\/"},{"@type":"ListItem","position":2,"name":"Glossary Terms","item":"https:\/\/www.rigicon.com\/es\/urology-glossary\/"},{"@type":"ListItem","position":3,"name":"Monitorizaci\u00f3n Activa"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/es\/#website","url":"https:\/\/www.rigicon.com\/es\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/es\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/es\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.rigicon.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-term\/12067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-term"}],"about":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/types\/glossary-term"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/media?parent=12067"}],"wp:term":[{"taxonomy":"glossary-category","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-category?post=12067"},{"taxonomy":"glossary-product","embeddable":true,"href":"https:\/\/www.rigicon.com\/es\/wp-json\/wp\/v2\/glossary-product?post=12067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}